Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

OM:VIT B
OM:VIT BSoftware

Will Vitec Software Group's Recurring Revenue Dominance Shape Its Global Ambitions? (OM:VIT B)

Vitec Software Group AB reported third quarter and nine-month 2025 earnings, with sales increasing to SEK773.22 million and SEK2.37 billion, respectively, while net income and earnings per share saw minor declines year-over-year. An interesting detail is that recurring revenue accounted for 90% of total sales, highlighting the company’s focus on stable, reliable income streams. Next, we'll explore how Vitec’s international expansion and resilient recurring revenue base inform its current...
NasdaqGS:NTGR
NasdaqGS:NTGRCommunications

A Fresh Look at NETGEAR (NTGR) Valuation Following Recent Share Price Gains

NETGEAR (NTGR) shares have seen some interesting movement recently, with the stock gaining over 13% in the past month. Investors may be weighing the company’s steady annual revenue growth as well as ongoing changes in the tech sector. See our latest analysis for NETGEAR. While NETGEAR's 1-month share price return of 13.2% signals renewed momentum, the stock's 1-year total shareholder return stands at an impressive 50.7%. This suggests that although gains have recently accelerated, long-term...
NasdaqCM:BLFS
NasdaqCM:BLFSLife Sciences

Is There Still Opportunity in BioLife Solutions After 15% Share Price Gain in 2025?

Thinking about what to do next with BioLife Solutions stock? You are not alone. Over the past year, shares have quietly climbed 15.6%, and while that performance might catch your eye, it is the bigger context that makes this stock so interesting right now. Investors have watched it rebound 6.8% in just the last 30 days, adding to a 4.4% gain year-to-date. Yet, when looking further back, the five-year total return lags at -5.9%, painting a far more complex picture. So, what is driving this...
HLSE:ALMA
HLSE:ALMAMedia

Alma Media Oyj (HLSE:ALMA) Is Up 7.5% After Upward 2025 Revenue Guidance Revision - What's Changed

On October 14, 2025, Alma Media Corporation revised its earnings guidance, announcing that its 2025 revenue is now expected to remain at or exceed the 2024 level of €312.7 million, rather than remaining flat as previously projected. This updated forecast highlights Alma Media's continued favorable business performance and the positive impact of recent acquisitions, particularly Edilex Oy and Effortia Oy, amid ongoing market uncertainty. We'll explore how Alma Media's upward revenue guidance...
NasdaqCM:CYRX
NasdaqCM:CYRXLife Sciences

Could Cryoport's (CYRX) New Monitoring Tech Reveal Its Strategy for Digital Cold Chain Leadership?

Cryoport, Inc. recently unveiled new integrated condition monitoring solutions for its MVE Biological Solutions dewars, incorporating the SmartTag and CryoBeacon devices powered by Tec4Med, with data centralized in the FDA-compliant MVECloud platform for enhanced monitoring of cryogenic storage. This innovation offers life sciences companies real-time visibility and improved safety for temperature-sensitive commodities, reflecting an ongoing push toward advanced digital and compliance...
NasdaqGM:QSI
NasdaqGM:QSILife Sciences

Can Quantum-Si's (QSI) V4 Kit Innovation Deepen Its Edge in the Protein Sequencing Race?

Quantum-Si recently introduced its V4 Sequencing Kit, designed to enhance protein analysis by expanding sequencing coverage and improving detection of specific amino acids. This technological advance stands out for its potential to significantly strengthen the company’s protein sequencing platform in the evolving life sciences sector. We'll look at how the V4 Sequencing Kit's improved capabilities shape Quantum-Si's investment narrative amid shifting market attention. Find companies with...
SEHK:1177
SEHK:1177Pharmaceuticals

Does Sino Biopharm Offer Value After Jumping 135% and Expanding in Asia in 2025?

If you have been watching Sino Biopharmaceutical, you are probably wondering what to make of this stock after such a rollercoaster ride. The past year has brought a surge that few predicted, with the stock up an eye-catching 135.6% since the start of the year and 95.3% over the last twelve months. Even looking back three years, the company has notched an impressive 83.5% gain. Yet, this momentum hit a speed bump recently, with prices dropping 6.7% in the last week and falling 13.2% over the...
NasdaqCM:RCEL
NasdaqCM:RCELBiotechs

A Look at AVITA Medical (RCEL) Valuation Following CEO Change and Preliminary Q3 Revenue Miss

AVITA Medical (RCEL) shares have drawn attention after Chairman Cary Vance was named Interim CEO, replacing Jim Corbett. This leadership shift comes as preliminary third-quarter revenue comes in below expectations and ongoing talks with lenders continue. See our latest analysis for AVITA Medical. Shares of AVITA Medical have struggled through 2025, with the 1-day share price return plunging 25.84% after the CEO transition and softer revenue update. Short-term momentum has clearly faded. With...
HLSE:TNOM
HLSE:TNOMProfessional Services

Talenom (HLSE:TNOM) Earnings Growth of 61.8% Reinforces Turnaround Narrative

Talenom Oyj (HLSE:TNOM) delivered headline numbers that point to a turnaround story, with revenue forecast to grow 7.7% per year, well above the Finnish market's 4% annual pace. EPS momentum is clear, as the company posted a striking 61.8% earnings growth rate over the past year, compared to a five-year average of negative 14.2% per year. Net profit margins now stand at 4.8% versus last year's 3%, underscoring an improvement in underlying profitability and the quality of earnings. See our...
OM:ITECH
OM:ITECHChemicals

I-Tech (OM:ITECH) Delivers 68% Earnings Growth, Reinforcing Profitability Narrative Despite Valuation Concerns

I-Tech (OM:ITECH) posted standout numbers this period, delivering annual earnings growth of 68.4% and pushing net profit margins up to 21.1% from last year’s 17%. With earnings forecast to grow 24.99% and revenue expected to climb 16.4% annually, both outpacing the Swedish market, investors saw a stock trading at SEK84, well below its estimated fair value of SEK310.67. While the company’s strong growth and robust margins are drawing positive attention, some are weighing these results against...
NasdaqCM:DOGZ
NasdaqCM:DOGZLuxury

Dogness (DOGZ) Losses Accelerate 13.9% Annually, High Valuation Raises Investor Caution

Dogness (International) (DOGZ) remains unprofitable, with losses having grown at a compounded rate of 13.9% annually over the past five years. The company’s net profit margin has failed to improve, and there are no signs of a turnaround or positive profit growth in recent periods. See our full analysis for Dogness (International). Next, we will see how the latest numbers measure up against the key narratives followed by the market. We will also consider whether popular views on DOGZ are still...